Dinesh Chandra Doval Selected Research

human CCND1 protein

1/2014

Expression of epidermal growth factor receptor, p53, Bcl2, vascular endothelial growth factor, cyclooxygenase-2, cyclin D1, human epidermal receptor-2 and Ki-67: Association with clinicopathological profiles and outcomes in gallbladder carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dinesh Chandra Doval Research Topics

Disease

12	Neoplasms (Cancer) 01/2019 - 03/2009
8	Breast Neoplasms (Breast Cancer) 12/2022 - 09/2013
5	Carcinoma (Carcinomatosis) 10/2020 - 06/2010
5	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2013
3	Gallbladder Neoplasms (Gallbladder Cancer) 10/2020 - 06/2010
3	Triple Negative Breast Neoplasms 04/2020 - 01/2014
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2018 - 01/2017
2	Disease Progression 01/2017 - 10/2016
2	Adenocarcinoma of Lung 10/2016 - 01/2013
1	Stomatitis 12/2022
1	Fatigue 12/2022
1	Neutropenia 12/2022
1	Mouth Neoplasms (Oral Cancer) 11/2021
1	Papillomavirus Infections 11/2021
1	Osteosarcoma (Osteogenic Sarcoma) 01/2021
1	Angiomyolipoma 11/2019
1	Pathologic Complete Response 04/2019
1	Diarrhea 01/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2018
1	Lung Neoplasms (Lung Cancer) 01/2018
1	Lymphoma (Lymphomas) 01/2017
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017
1	Superior Vena Cava Syndrome (Superior Vena Cava Obstruction) 06/2010
1	Thrombosis (Thrombus) 06/2010
1	Spinal Cord Compression 08/2006
1	Paraplegia (Spastic Paraplegia) 08/2006

Drug/Important Bio-Agent (IBA)

6	ErbB Receptors (EGF Receptor)IBA 12/2022 - 06/2010
5	Hormones (Hormone)IBA 12/2022 - 01/2015
3	Estrogen ReceptorsIBA 12/2022 - 01/2014
3	Gemcitabine FDA Link 10/2020 - 12/2014
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2017
2	palbociclibIBA 12/2022 - 10/2021
2	Formaldehyde (Formol)FDA Link 11/2021 - 01/2014
2	ParaffinIBA 11/2021 - 01/2014
2	Cadherins (E-Cadherin)IBA 01/2019 - 01/2018
2	Gefitinib (Iressa)FDA Link 01/2018 - 06/2010
2	PlatinumIBA 10/2016 - 01/2016
2	Epidermal Growth Factor (EGF)IBA 01/2015 - 01/2014
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2015 - 01/2014
1	Letrozole (Femara)FDA LinkGeneric 12/2022
1	DNA (Deoxyribonucleic Acid)IBA 11/2021
1	Xylenes (Xylene)IBA 11/2021
1	Cyclin-Dependent Kinase 4IBA 10/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	Ifosfamide FDA LinkGeneric 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Imatinib Mesylate (Gleevec)FDA Link 11/2019
1	CrizotinibIBA 11/2019
1	Everolimus FDA Link 11/2019
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2017
1	Cetuximab (Erbitux)FDA Link 01/2017
1	Pemetrexed (MTA)FDA Link 10/2016
1	ErbB-2 ReceptorIBA 01/2015
1	human CCND1 proteinIBA 01/2014
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014
1	Trastuzumab (Herceptin)FDA Link 09/2013
1	Codon (Codons)IBA 01/2013
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2013
1	MucinsIBA 03/2009

Therapy/Procedure

8	Therapeutics 12/2022 - 06/2010
6	Drug Therapy (Chemotherapy) 01/2021 - 12/2014
3	Neoadjuvant Therapy 04/2020 - 09/2013
2	Radiotherapy 01/2017 - 06/2010
2	Cholecystectomy 01/2014 - 06/2010
1	Oral Medicine 11/2021
1	Metastasectomy 07/2018
1	Drug Tapering 01/2018
1	Induction Chemotherapy 10/2016
1	Vegetarian Diet (Vegetarianism) 01/2015
1	Immunotherapy 09/2013
1	Laminectomy 08/2006
1	Treatment Delay 08/2006